Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Open in API
Filings indexed 643 across all filing types
Latest filing 2024-03-06 Report Publication Anno…
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Invitation to Observe Medical ASA second half and full year 2023 presentation and Q&A
Report Publication Announcement Classification · 98% confidence The document is an invitation announcing when the company, Observe Medical, will release its results for the second half and full year 2023 (scheduled for March 13, 2024) and inviting stakeholders to an accompanying presentation and Q&A session. It explicitly states that the results presentation will be published on NewsWeb and the Company's website on that date. Since the document itself is an announcement about the publication of financial results and an invitation to an event related to those results, rather than the full financial report (10-K or IR) or the initial highlights (ER), it fits best under the category for announcing the release of reports. This aligns with the definition of Report Publication Announcement (RPA). The document length (2394 chars) is short, supporting the 'announcement' classification over the full report classification.
2024-03-06 English
Invitation to Observe Medical ASA second half and full year 2023 presentation and Q&A
Report Publication Announcement Classification · 98% confidence The document is an invitation announcing the upcoming release of the second half and full-year 2023 results, scheduled for March 13, 2024. It details the time and method for observing the presentation and Q&A session (in-person, webcast, and subsequent availability of materials). Since the document itself is not the financial report (ER or IR) but rather an announcement about when and how to access that report and associated presentation, it fits the definition of a Report Publication Announcement (RPA). The document length (2490 chars) is short, supporting the 'MENU VS MEAL' rule.
2024-03-06 English
Observe Medical - Organizational changes
Board/Management Information Classification · 100% confidence The document explicitly announces organizational changes, specifically the stepping down of the CEO (Rune Nystad) and the appointment of an interim CEO (Jørgen Mann), along with a role change for the outgoing CEO. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2024-02-29 English
Observe Medical - Organizational changes
Board/Management Information Classification · 100% confidence The document explicitly announces organizational changes, specifically the stepping down of the CEO (Rune Nystad) and the appointment of an interim CEO (Jørgen Mann), along with a role change for the former CEO. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-02-29 English
Observe Medical - First order to Germany
Regulatory Filings Classification · 95% confidence The document is a short press release dated February 28, 2024, announcing a specific business event: receiving the first order for UnoMeter products from a new German distributor (Siramo GmbH) following a previous LOI. It contains key highlights, quotes from management, and contact information, but it is not a comprehensive financial report (like 10-K or IR), a transcript (CT), or a formal regulatory filing detailing ownership changes or dividends. This type of announcement, focusing on a specific commercial milestone or partnership update, is best classified as a general Regulatory Filing (RNS) as it is a public disclosure that doesn't fit the more specific categories like ER, CAP, or M&A. Given its nature as a brief, non-financial operational update, RNS is the most appropriate fallback.
2024-02-28 English
Observe Medical - First order to Germany
Regulatory Filings Classification · 99% confidence The document is a short press release dated February 28, 2024, announcing a specific business event: receiving the first order for UnoMeter products from a new distributor (Siramo GmbH) in Germany, following a previous LOI. This is a material, non-financial operational update. It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a formal regulatory filing like a Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since it is a specific business announcement that doesn't fit the other specialized categories (like M&A, Capital, Dividend, etc.), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a catch-all for significant, non-standard announcements, or potentially a general announcement if RNS is interpreted strictly as exchange filings. Given the context of a press release announcing a commercial milestone, RNS is the most appropriate general classification.
2024-02-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.